HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian D Gray Selected Research

Breast Neoplasms (Breast Cancer)

1/2017Liposomes Containing Lipid-Soluble Zn(II)-Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells.
11/2013Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian D Gray Research Topics

Disease

16Neoplasms (Cancer)
03/2024 - 11/2004
3Atherosclerosis
01/2018 - 11/2004
3Infections
07/2012 - 04/2012
2Necrosis
10/2023 - 04/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 10/2016
2Brain Neoplasms (Brain Tumor)
11/2021 - 01/2020
2Glioblastoma (Glioblastoma Multiforme)
11/2021 - 05/2016
2Atherosclerotic Plaque (Atheroma)
01/2018 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2017 - 11/2013
2Reperfusion Injury
06/2012 - 06/2011
1Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2024
1Arthritis (Polyarthritis)
03/2015
1Colonic Neoplasms (Colon Cancer)
10/2013
1Brain Infarction
01/2013
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2013
1Ischemia
01/2013
1Inflammation (Inflammations)
07/2012
1Bacterial Infections (Bacterial Infection)
07/2012
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2012
1Inborn Genetic Diseases (Disease, Hereditary)
11/2004
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2004
1Experimental Melanoma
11/2004

Drug/Important Bio-Agent (IBA)

8PhosphatidylserinesIBA
01/2020 - 04/2012
5Coloring Agents (Dyes)IBA
10/2021 - 01/2006
4zinc(II) dipicolylamineIBA
11/2019 - 04/2012
3LipidsIBA
11/2021 - 11/2004
2Peptides (Polypeptides)IBA
01/2023 - 10/2016
2SaposinsIBA
11/2021 - 01/2020
2Liposomes (Liposome)IBA
11/2021 - 01/2017
2Apolipoproteins E (ApoE)IBA
01/2018 - 01/2016
2bis-dipicolylamine-Zinc(II)IBA
01/2017 - 07/2012
2Messenger RNA (mRNA)IBA
11/2013 - 10/2013
1Radioisotopes (Radionuclides)IBA
03/2024
1177Lu-octreotateIBA
03/2024
1Somatostatin Receptors (Somatostatin Receptor)IBA
03/2024
1Peptide Receptors (Peptide Receptor)IBA
03/2024
1Cisplatin (Platino)FDA LinkGeneric
10/2023
1Glucaric AcidIBA
10/2023
1phenylalanylserineIBA
01/2023
1prolyl-serine (Pro-Ser)IBA
01/2023
1hydroxide ionIBA
01/2023
1Proteins (Proteins, Gene)FDA Link
11/2021
1Temozolomide (Temodar)FDA LinkGeneric
11/2021
1phosphatidylethanolamineIBA
11/2019
1compound 17IBA
11/2019
1Annexin A5IBA
01/2018
1duramycinIBA
01/2018
1Irinotecan (Camptosar)FDA LinkGeneric
01/2017
12,2'-dipicolylamineIBA
01/2017
1Molecular Probes (Molecular Probe)IBA
10/2016
1Iodine-125IBA
05/2016
1IodineIBA
05/2016
1ApolipoproteinsIBA
01/2016
1CollagenIBA
03/2015
1human ERBB2 proteinIBA
11/2013
1GuanineIBA
10/2013
1Peptide Nucleic AcidsIBA
10/2013
1Codon (Codons)IBA
10/2013
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2013
1LipopolysaccharidesIBA
07/2012
1DOTA-biotin (90Y-DOTA-biotin)IBA
07/2012
1Biotin (Vitamin H)FDA Link
07/2012
1technetium Tc 99m glucarateIBA
06/2012
1Hematoxylin (Haematoxylon)IBA
06/2012
1Eosine Yellowish-(YS) (Eosin)IBA
06/2012
1Caspase 3 (Caspase-3)IBA
06/2012
1Coordination ComplexesIBA
06/2011
1Green Fluorescent ProteinsIBA
01/2006
1oxidized low density lipoproteinIBA
11/2004
1LDL Receptors (LDL Receptor)IBA
11/2004

Therapy/Procedure

5Therapeutics
03/2024 - 11/2004
3Aftercare (After-Treatment)
03/2024 - 11/2013
2Drug Therapy (Chemotherapy)
10/2023 - 11/2021
1Precision Medicine
03/2024
1Radiotherapy
11/2021
1Biological Therapy
01/2020
1Intravenous Injections
01/2006